Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Vir Biotechnology, Inc. | Director | Common Stock | 1.32M | $12.5M | $9.46 | May 30, 2024 | Direct |
Denali Therapeutics Inc. | Director | Common Stock | 115K | $3.45M | $30.00 | Sep 13, 2024 | Direct |
Allogene Therapeutics, Inc. | Director | Common Stock | 163K | $380K | $2.34 | Jun 5, 2024 | Direct |
Vir Biotechnology, Inc. | Director | Stock Option (Right to Buy) | 16K | $24.5K | $1.53 | May 30, 2024 | Direct |
Allogene Therapeutics, Inc. | Director | Stock Option (Right to buy) | 95.5K | Jun 5, 2024 | Direct | ||
Denali Therapeutics Inc. | Director | Stock Option (right to buy) | 17.9K | May 31, 2024 | Direct | ||
Akouos, Inc. | Director | Stock Option (right to buy) | 0 | Dec 1, 2022 | Direct |